Disclosures for "Efficacy and Safety of Plasma Exchange in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Disease in Adults: A Systematic Review and Meta-analysis"
-
Miss Vilardo has nothing to disclose.
-
Miss Leles Vieira de Souza has nothing to disclose.
-
Dr. Mahler has received research support from The Sumaira Foundation.
-
Mr. Cardoso has nothing to disclose.
-
Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer.